| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |